Tabata T - Search Results

1

Circulating bone Gla protein in end-stage renal disease determined by newly developed two-site immunoradiometric assay.

Nakatsuka K, Miki T, Nishizawa Y, Tabata T, Inoue T, Morii H, Ogata E. Nakatsuka K, et al. Among authors: tabata t. Contrib Nephrol. 1991;90:147-54. doi: 10.1159/000420137. Contrib Nephrol. 1991. PMID: 1959340

2

Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.

Shoji T, Nishizawa Y, Kawagishi T, Kawasaki K, Taniwaki H, Tabata T, Inoue T, Morii H. Shoji T, et al. Among authors: tabata t. J Am Soc Nephrol. 1998 Jul;9(7):1277-84. doi: 10.1681/ASN.V971277. J Am Soc Nephrol. 1998. PMID: 9644639 Clinical Trial.

3

Atherogenic lipoproteins in end-stage renal disease.

Shoji T, Ishimura E, Inaba M, Tabata T, Nishizawa Y. Shoji T, et al. Among authors: tabata t. Am J Kidney Dis. 2001 Oct;38(4 Suppl 1):S30-3. doi: 10.1053/ajkd.2001.27393. Am J Kidney Dis. 2001. PMID: 11576918 Review.

4

Plasma 1,5-anhydroglucitol concentration in patients with end-stage renal disease with and without diabetes mellitus.

Emoto M, Tabata T, Inoue T, Nishizawa Y, Morii H. Emoto M, et al. Among authors: tabata t. Nephron. 1992;61(2):181-6. doi: 10.1159/000186868. Nephron. 1992. PMID: 1630543

5

Effect of intermittent oral 1,25(OH)2D3 therapy on bone Gla protein in dialysis patients.

Miki T, Nakatsuka K, Nishizawa Y, Emoto M, Morita A, Tabata T, Matsushita Y, Inoue T, Morii H. Miki T, et al. Among authors: tabata t. Endocrinol Jpn. 1991 Oct;38(5):479-83. doi: 10.1507/endocrj1954.38.479. Endocrinol Jpn. 1991. PMID: 1843267 Free article.

6

Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.

Shoji T, Nishizawa Y, Kawagishi T, Tanaka M, Kawasaki K, Tabata T, Inoue T, Morii H. Shoji T, et al. Among authors: tabata t. Atherosclerosis. 1997 Jun;131(2):229-36. doi: 10.1016/s0021-9150(97)00054-3. Atherosclerosis. 1997. PMID: 9199276

7

Plasma leptin level and its relationship with body composition in hemodialysis patients.

Nishizawa Y, Shoji T, Tanaka S, Yamashita M, Morita A, Emoto M, Tabata T, Inoue T, Morii H. Nishizawa Y, et al. Among authors: tabata t. Am J Kidney Dis. 1998 Apr;31(4):655-61. doi: 10.1053/ajkd.1998.v31.pm9531182. Am J Kidney Dis. 1998. PMID: 9531182

8

Changes in bone mineral density at various sites in patients on hemodialysis due to chronic glomerulonephritis.

Miki T, Morita A, Nakatsuka K, Tabata T, Inoue T, Nishizawa Y, Morii H. Miki T, et al. Among authors: tabata t. Osteoporos Int. 1997;7 Suppl 3:S193-6. doi: 10.1007/BF03194371. Osteoporos Int. 1997. PMID: 9536331 No abstract available.

9

Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.

Tsujimoto Y, Shoji T, Tabata T, Morita A, Emoto M, Nishizawa Y, Morii H. Tsujimoto Y, et al. Among authors: tabata t. Am J Kidney Dis. 1999 Nov;34(5):832-8. doi: 10.1016/S0272-6386(99)70039-9. Am J Kidney Dis. 1999. PMID: 10561138

10

A two-site immunochemiluminometric assay for intact parathyroid hormone and its clinical utility in hemodialysis patients.

Morita A, Tabata T, Koyama H, Emoto M, Inoue T, Miki T, Nishizawa Y, Morii H. Morita A, et al. Among authors: tabata t. Clin Nephrol. 1992 Sep;38(3):154-7. Clin Nephrol. 1992. PMID: 1395169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,003 results

Search Page

Filters